EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dendrophenol Mitigates Inflammatory Sickness Behaviors and Maintains CNS Function in Murine Models

Hasriadi Hasriadi, Peththa Wadu Dasuni Wasana, Boonchoo Sritularak, Opa Vajragupta, Pornchai Rojsitthisak, Pasarapa Towiwat

Medicine in Drug Discovery · 2026-05 · 30 · 100255

DOI: 10.1016/j.medidd.2026.100255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine in Drug Discovery, 2026-05. Verfasst von Hasriadi Hasriadi und 5 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Thailand Science Research and Innovation, Chulalongkorn University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• Dendrophenol dose-dependently attenuates inflammatory sickness behaviors. • Dendrophenol suppresses key pro-inflammatory mediators (TNF-α, IL-6, IL-1β, MCP-1) in vivo and in vitro. • Dendrophenol maintains CNS safety without adverse neurological effects. Inflammatory sickness behaviors—characterized by reduced mobility, anhedonia, and social withdrawal—represent significant clinical manifestations of systemic inflammation and immune activation. This study evaluated the pharmacological effects and mechanism of action of dendrophenol, a bioactive compound from Dendrobium senile , in preclinical models of inflammatory disease. Male mice received dendrophenol (12.5, 25, 50 mg/kg, i.p.) in acute inflammation models (LPS-induced endotoxemia and formalin-induced inflammation). Pharmacological efficacy was assessed via behavioral phenotyping, inflammatory marker quantification, and CNS safety evaluation. Dendrophenol demonstrated dose-dependent attenuation of sickness behaviors in both LPS and formalin models. Mechanistic studies revealed that dendrophenol suppressed systemic and central pro-inflammatory mediators (TNF-α, IL-6, IL-1β, MCP-1) in vivo. Cellular mechanistic validation in LPS-stimulated macrophages and microglia demonstrated that dendrophenol inhibited inflammatory immune cell activation and cytokine release. Critically, dendrophenol produced no effects on locomotor activity and general behaviors, confirming CNS safety at all tested doses. These findings establish dendrophenol as a pharmacologically active anti-inflammatory compound with favorable safety characteristics, supporting preclinical validation for further drug development in inflammation-associated pathologies. The compound warrants advancement to dose-escalation and pharmacokinetic studies.

Förderung

  • Thailand Science Research and Innovation
  • Chulalongkorn University

Zitieren

APA

Hasriadi, H., Wasana, P. W. D., Sritularak, B., Vajragupta, O., Rojsitthisak, P., & Towiwat, P. (2026). Dendrophenol Mitigates Inflammatory Sickness Behaviors and Maintains CNS Function in Murine Models. Medicine in Drug Discovery, 30, 100255. https://doi.org/10.1016/j.medidd.2026.100255

Vancouver

Hasriadi H, Wasana PWD, Sritularak B, Vajragupta O, Rojsitthisak P, Towiwat P. Dendrophenol Mitigates Inflammatory Sickness Behaviors and Maintains CNS Function in Murine Models. Medicine in Drug Discovery. 2026;30:100255. doi:10.1016/j.medidd.2026.100255

BibTeX
@article{Hasriadi2026,
  author = {Hasriadi, Hasriadi and Wasana, Peththa Wadu Dasuni and Sritularak, Boonchoo and Vajragupta, Opa and Rojsitthisak, Pornchai and Towiwat, Pasarapa},
  title = {Dendrophenol Mitigates Inflammatory Sickness Behaviors and Maintains CNS Function in Murine Models},
  journal = {Medicine in Drug Discovery},
  year = {2026},
  volume = {30},
  pages = {100255},
  doi = {10.1016/j.medidd.2026.100255}
}
Kostenlos starten →